The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Small Molecule Drug CDMD Services Market Research Report 2024
Synopsis
Small molecule drugs refer to relatively small organic molecules that usually enter the body through oral administration or other routes and are used to treat diseases. Small molecule drug services provided by Contract Development and Manufacturing Organizations (CDMOs) cover the entire drug development and manufacturing process.
The global Small Molecule Drug CDMD Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Small Molecule Drug CDMD Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Small Molecule Drug CDMD Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Small Molecule Drug CDMD Services in Business Use is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Small Molecule Drug CDMD Services include Thermo Fisher Scientific, Catalent, Lonza, Asymchem, Delpharm, Aenova Group, Siegfried Holding, Recipharm AB and Fareva, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Molecule Drug CDMD Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Drug CDMD Services.
Report Scope
The Small Molecule Drug CDMD Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Molecule Drug CDMD Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule Drug CDMD Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Catalent
Lonza
Asymchem
Delpharm
Aenova Group
Siegfried Holding
Recipharm AB
Fareva
Almac
Cambrex
WuXi AppTec
Charles River
CordenPharma
Jubilant Pharmova
Pharmaron Inc.
Porton
Jiuzhou Pharmaceutical
Zhejiang Apeloa
HwaGen
Segment by Type
Active Pharmaceutical Ingredients and Intermediates
Finished Type
Segment by Application
Business Use
Academic Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule Drug CDMD Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Small molecule drugs refer to relatively small organic molecules that usually enter the body through oral administration or other routes and are used to treat diseases. Small molecule drug services provided by Contract Development and Manufacturing Organizations (CDMOs) cover the entire drug development and manufacturing process.
The global Small Molecule Drug CDMD Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Small Molecule Drug CDMD Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Small Molecule Drug CDMD Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Small Molecule Drug CDMD Services in Business Use is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Small Molecule Drug CDMD Services include Thermo Fisher Scientific, Catalent, Lonza, Asymchem, Delpharm, Aenova Group, Siegfried Holding, Recipharm AB and Fareva, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Molecule Drug CDMD Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Drug CDMD Services.
Report Scope
The Small Molecule Drug CDMD Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Molecule Drug CDMD Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule Drug CDMD Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Catalent
Lonza
Asymchem
Delpharm
Aenova Group
Siegfried Holding
Recipharm AB
Fareva
Almac
Cambrex
WuXi AppTec
Charles River
CordenPharma
Jubilant Pharmova
Pharmaron Inc.
Porton
Jiuzhou Pharmaceutical
Zhejiang Apeloa
HwaGen
Segment by Type
Active Pharmaceutical Ingredients and Intermediates
Finished Type
Segment by Application
Business Use
Academic Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule Drug CDMD Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Drug CDMD Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Active Pharmaceutical Ingredients and Intermediates
1.2.3 Finished Type
1.3 Market by Application
1.3.1 Global Small Molecule Drug CDMD Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Business Use
1.3.3 Academic Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Drug CDMD Services Market Perspective (2019-2030)
2.2 Small Molecule Drug CDMD Services Growth Trends by Region
2.2.1 Global Small Molecule Drug CDMD Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Small Molecule Drug CDMD Services Historic Market Size by Region (2019-2024)
2.2.3 Small Molecule Drug CDMD Services Forecasted Market Size by Region (2025-2030)
2.3 Small Molecule Drug CDMD Services Market Dynamics
2.3.1 Small Molecule Drug CDMD Services Industry Trends
2.3.2 Small Molecule Drug CDMD Services Market Drivers
2.3.3 Small Molecule Drug CDMD Services Market Challenges
2.3.4 Small Molecule Drug CDMD Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Drug CDMD Services Players by Revenue
3.1.1 Global Top Small Molecule Drug CDMD Services Players by Revenue (2019-2024)
3.1.2 Global Small Molecule Drug CDMD Services Revenue Market Share by Players (2019-2024)
3.2 Global Small Molecule Drug CDMD Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Small Molecule Drug CDMD Services Revenue
3.4 Global Small Molecule Drug CDMD Services Market Concentration Ratio
3.4.1 Global Small Molecule Drug CDMD Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Drug CDMD Services Revenue in 2023
3.5 Small Molecule Drug CDMD Services Key Players Head office and Area Served
3.6 Key Players Small Molecule Drug CDMD Services Product Solution and Service
3.7 Date of Enter into Small Molecule Drug CDMD Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Drug CDMD Services Breakdown Data by Type
4.1 Global Small Molecule Drug CDMD Services Historic Market Size by Type (2019-2024)
4.2 Global Small Molecule Drug CDMD Services Forecasted Market Size by Type (2025-2030)
5 Small Molecule Drug CDMD Services Breakdown Data by Application
5.1 Global Small Molecule Drug CDMD Services Historic Market Size by Application (2019-2024)
5.2 Global Small Molecule Drug CDMD Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Small Molecule Drug CDMD Services Market Size (2019-2030)
6.2 North America Small Molecule Drug CDMD Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Small Molecule Drug CDMD Services Market Size by Country (2019-2024)
6.4 North America Small Molecule Drug CDMD Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule Drug CDMD Services Market Size (2019-2030)
7.2 Europe Small Molecule Drug CDMD Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Small Molecule Drug CDMD Services Market Size by Country (2019-2024)
7.4 Europe Small Molecule Drug CDMD Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Drug CDMD Services Market Size (2019-2030)
8.2 Asia-Pacific Small Molecule Drug CDMD Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Small Molecule Drug CDMD Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Small Molecule Drug CDMD Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Molecule Drug CDMD Services Market Size (2019-2030)
9.2 Latin America Small Molecule Drug CDMD Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Small Molecule Drug CDMD Services Market Size by Country (2019-2024)
9.4 Latin America Small Molecule Drug CDMD Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Drug CDMD Services Market Size (2019-2030)
10.2 Middle East & Africa Small Molecule Drug CDMD Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Small Molecule Drug CDMD Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Small Molecule Drug CDMD Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Small Molecule Drug CDMD Services Introduction
11.1.4 Thermo Fisher Scientific Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Catalent
11.2.1 Catalent Company Detail
11.2.2 Catalent Business Overview
11.2.3 Catalent Small Molecule Drug CDMD Services Introduction
11.2.4 Catalent Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.2.5 Catalent Recent Development
11.3 Lonza
11.3.1 Lonza Company Detail
11.3.2 Lonza Business Overview
11.3.3 Lonza Small Molecule Drug CDMD Services Introduction
11.3.4 Lonza Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.3.5 Lonza Recent Development
11.4 Asymchem
11.4.1 Asymchem Company Detail
11.4.2 Asymchem Business Overview
11.4.3 Asymchem Small Molecule Drug CDMD Services Introduction
11.4.4 Asymchem Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.4.5 Asymchem Recent Development
11.5 Delpharm
11.5.1 Delpharm Company Detail
11.5.2 Delpharm Business Overview
11.5.3 Delpharm Small Molecule Drug CDMD Services Introduction
11.5.4 Delpharm Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.5.5 Delpharm Recent Development
11.6 Aenova Group
11.6.1 Aenova Group Company Detail
11.6.2 Aenova Group Business Overview
11.6.3 Aenova Group Small Molecule Drug CDMD Services Introduction
11.6.4 Aenova Group Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.6.5 Aenova Group Recent Development
11.7 Siegfried Holding
11.7.1 Siegfried Holding Company Detail
11.7.2 Siegfried Holding Business Overview
11.7.3 Siegfried Holding Small Molecule Drug CDMD Services Introduction
11.7.4 Siegfried Holding Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.7.5 Siegfried Holding Recent Development
11.8 Recipharm AB
11.8.1 Recipharm AB Company Detail
11.8.2 Recipharm AB Business Overview
11.8.3 Recipharm AB Small Molecule Drug CDMD Services Introduction
11.8.4 Recipharm AB Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.8.5 Recipharm AB Recent Development
11.9 Fareva
11.9.1 Fareva Company Detail
11.9.2 Fareva Business Overview
11.9.3 Fareva Small Molecule Drug CDMD Services Introduction
11.9.4 Fareva Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.9.5 Fareva Recent Development
11.10 Almac
11.10.1 Almac Company Detail
11.10.2 Almac Business Overview
11.10.3 Almac Small Molecule Drug CDMD Services Introduction
11.10.4 Almac Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.10.5 Almac Recent Development
11.11 Cambrex
11.11.1 Cambrex Company Detail
11.11.2 Cambrex Business Overview
11.11.3 Cambrex Small Molecule Drug CDMD Services Introduction
11.11.4 Cambrex Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.11.5 Cambrex Recent Development
11.12 WuXi AppTec
11.12.1 WuXi AppTec Company Detail
11.12.2 WuXi AppTec Business Overview
11.12.3 WuXi AppTec Small Molecule Drug CDMD Services Introduction
11.12.4 WuXi AppTec Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.12.5 WuXi AppTec Recent Development
11.13 Charles River
11.13.1 Charles River Company Detail
11.13.2 Charles River Business Overview
11.13.3 Charles River Small Molecule Drug CDMD Services Introduction
11.13.4 Charles River Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.13.5 Charles River Recent Development
11.14 CordenPharma
11.14.1 CordenPharma Company Detail
11.14.2 CordenPharma Business Overview
11.14.3 CordenPharma Small Molecule Drug CDMD Services Introduction
11.14.4 CordenPharma Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.14.5 CordenPharma Recent Development
11.15 Jubilant Pharmova
11.15.1 Jubilant Pharmova Company Detail
11.15.2 Jubilant Pharmova Business Overview
11.15.3 Jubilant Pharmova Small Molecule Drug CDMD Services Introduction
11.15.4 Jubilant Pharmova Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.15.5 Jubilant Pharmova Recent Development
11.16 Pharmaron Inc.
11.16.1 Pharmaron Inc. Company Detail
11.16.2 Pharmaron Inc. Business Overview
11.16.3 Pharmaron Inc. Small Molecule Drug CDMD Services Introduction
11.16.4 Pharmaron Inc. Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.16.5 Pharmaron Inc. Recent Development
11.17 Porton
11.17.1 Porton Company Detail
11.17.2 Porton Business Overview
11.17.3 Porton Small Molecule Drug CDMD Services Introduction
11.17.4 Porton Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.17.5 Porton Recent Development
11.18 Jiuzhou Pharmaceutical
11.18.1 Jiuzhou Pharmaceutical Company Detail
11.18.2 Jiuzhou Pharmaceutical Business Overview
11.18.3 Jiuzhou Pharmaceutical Small Molecule Drug CDMD Services Introduction
11.18.4 Jiuzhou Pharmaceutical Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.18.5 Jiuzhou Pharmaceutical Recent Development
11.19 Zhejiang Apeloa
11.19.1 Zhejiang Apeloa Company Detail
11.19.2 Zhejiang Apeloa Business Overview
11.19.3 Zhejiang Apeloa Small Molecule Drug CDMD Services Introduction
11.19.4 Zhejiang Apeloa Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.19.5 Zhejiang Apeloa Recent Development
11.20 HwaGen
11.20.1 HwaGen Company Detail
11.20.2 HwaGen Business Overview
11.20.3 HwaGen Small Molecule Drug CDMD Services Introduction
11.20.4 HwaGen Revenue in Small Molecule Drug CDMD Services Business (2019-2024)
11.20.5 HwaGen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
